Royalty Pharma plc - Ordinary Shares - Class A

NASDAQ:RPRX   3:59:58 PM EDT
38.69
-0.24 (-0.62%)
Other Pre-Announcement

Royalty Provides Business Update At 40th Annual J.P. Morgan Healthcare Conference

Published: 01/10/2022 12:55 GMT
Royalty Pharma plc - Ordinary Shares - Class A (RPRX) - Royalty Pharma - Highlights Accomplishments and Provides Business Update at 40th Annual Jp Morgan Healthcare Conference.
Royalty Pharma - 2021 Net Cash Provided by Operating Activities (GAAP) Expected to Be in the Range of $2.01 Billion to $2.03 Billion.
Royalty Pharma - 2021 Adjusted Cash Receipts (non-GAAP) Expected to Be at High End of Guidance Range of $2.11 Billion to $2.13 Billion.